Drug Action Exam 3 Flashcards
radial muscle adrenergic receptor and effect
alpha-1, contraction causing dilation of pupil
radial muscle cholinergic receptor and action
None
mydriasis
dilation of pupil
miosis
shrinking of pupil
iris sphincter cholinergic receptor and effect
M3; contraction causing miosis
iris sphincter adrenergic receptor and effect
none
ciliary epithelium cholinergic receptor and effect
none
ciliary epithelium adrenergic receptor and effect
beta-2 increase aqueous producting increase IOP < alpha-2 decreases aqueous production decrease IOP
trabecular meshwork cholinergic receptor and effect
none
trabecular meshwork adrenergic receptor and effect
beta-2 increase aqueous outflow decrease IOP
atria and ventricles cholinergic receptor and effect
M2>M3, decrease contractility and force
atria and ventricles adrenergic receptor and effect
beta-1>beta-2; increase contractility and force
SA and AV nodes cholinergic receptor and effect
M2>M3; decrease heart rate
SA and AV nodes adrenergic receptor and effect
beta-1>beta-2; increase heart rate
arteries and veins cholinergic receptor and effect
M3; vasodilation, decreased BP
arteries and veins adrenergic receptor and effect
alpha-1, vasoconstriction increased BP
alpha-2, beta-2, vasodilation decreased BP
skeletal muscle blood vessels cholinergic receptor and effect
none
skeletal muscle blood vessels adrenergic receptors and effect
beta-2, vasodilation
bronchial smooth muscle cholinergic receptor and effect
M3, bronchoconstriction
bronchial smooth muscle adrenergic receptor and effect
beta-2, bronchodilation
stomach motility and tone cholinergic receptor and effect
M2, M3; increased motility and tone
stomach motility and tone adrenergic receptor and effect
alpha-1, alpha-2, beta-1, beta-2; decreased motility and tone
GI sphincters cholinergic receptor and effect
M2,M3; relaxation
GI sphincters adrenergic receptor and effect
alpha-1; contraction
GI secretions cholinergic receptor and effect
M2, M3; increase secretions
GI secretions adrenergic receptor and effect
alpha-2; decrease secretion
renin release cholinergic receptor and effect
none
renin release adrenergic receptor and effect
beta-1, increase renin release
pancreas beta cells cholinergic receptor and effect
none
pancreas beta cells adrenergic receptor and effect
alpha-2 decrease insulin secretion > beta-2 increase insulin secretion
sweat glands cholinergic receptor and effect
none
sweat glands adrenergic receptor and effect
alpha-1 (localized), M2, M3; increase sweat
urinary bladder detrussor cholinergic receptor and effect
M3>M2; contraction
urinary bladder detrussor adrenergic receptor and effect
beta-2, beta-3 (dominant); relaxation
urinary bladder trigone and sphincter cholinergic receptor and effect
M3>M2; relaxation
urinary bladder trigone adrenergic receptor and effect
alpha-1, contraction
Epi is agonist at
alpha-1, alpha-2, beta-1, beta-2, beta-3
Norepi is agonist at
alpha-1, beta-1 > beta-2
glaucoma IOP
> 26 mmHg
pilocarpine eye
muscarinic agonist; open angle glaucoma, reverse mydriasis
benthanecol GI
increase GI motility postsurgery
pilocarpine GI
muscarinic agonist; xerostomia, Sjorgen’s syndrome; increase salivation/secretions
bethanochol GU
stimulates detrussor muscle to contract; for postop urinary retention
pyridostigmine
myasthenia gravis, treat nondepolarizing neuromuscular blockers; reversible AChEI
neostigmine
myasthenia gravis, reverse nondepolarizing neuromuscular blocking agents, treatment of postop urinary retential and intestinal atony; reversible AChEI
physostigmine
glaucoma, myasthenia gravis, treatment of overdose of agents with significant anticholinergic activity; reversible AChEI
donepezil
AD; reversible nonclassical AChEI
galantamine
AD; reversible nonclassical AChEI